Table 2 Fetal assessment at 22 weeks of gestation in both groups
From: Assessment of fetal growth and anomalies in the era of COVID-19 pandemic: an Egyptian pilot study
“Group A” (n = 30) | “Group B” (n = 60) | P value | |
|---|---|---|---|
BPD (22 weeks) | 56.93 ± 2.84 | 57.43 ± 2.94 | 0.444 |
HC (22 weeks) | 197.83 ± 9.65 | 200.67 ± 9.87 | 0.199 |
FL (22 weeks) | 36.63 ± 2.57 | 37.15 ± 2.84 | 0.403 |
AC (22 weeks) | 169.53 ± 12.16 | 169.05 ± 10.48 | 0.846 |
EFW (22 weeks) | 473.89 ± 56.22 | 479.43 ± 56.05 | 0.660 |
Mean uterine PI (22 weeks) | 1.07 ± 0.22 | 1.05 ± 0.22 | 0.766 |
Amniotic fluid: Average | 30 (100%) | 60 (100%) | NA |
Gross anomalies | 1 (3.33%) | 1 (1.67%) | 0.613 |